← Back to Search

Participants with T-Cell Lymphoma for Sezary Syndrome

N/A
Recruiting
Led By Steven Horwitz, MD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 years
Awards & highlights

Study Summary

The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the information from this database to learn more about how to improve outcomes for people with T-cell lymphoma.

Eligible Conditions
  • Sezary Syndrome
  • Epstein-Barr Virus Infection
  • Gastrointestinal Lymphoma
  • T-Cell Lymphoproliferative Disease of Childhood
  • Intestinal T-Cell Lymphoma
  • Anaplastic Large Cell Lymphoma
  • Chronic Lymphoproliferative Disorder
  • Peripheral T-Cell Lymphoma
  • Hydroa Vacciniforme-Like Lymphoproliferative Disorder
  • Cutaneous T-Cell Lymphoma
  • Mycosis Fungoides
  • Natural Killer Cell Lymphoma
  • T-Cell Lymphoma
  • Large Granular Lymphocytic Leukemia
  • Prolymphocytic Leukemia
  • Natural Killer Cell Leukemia
  • Enteropathy-associated T-cell Lymphoma
  • Hepatosplenic T-cell Lymphoma
  • Adult T-Cell Leukemia/Lymphoma
  • Nasal Lymphoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants populating the T-cell Lymphoma Master Repository/TCLMR

Trial Design

1Treatment groups
Experimental Treatment
Group I: Participants with T-Cell LymphomaExperimental Treatment1 Intervention
Participants with pathologically-confirmed mature T- or natural killer (NK)-cell lymphoma

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,936 Previous Clinical Trials
587,881 Total Patients Enrolled
2 Trials studying Sezary Syndrome
86 Patients Enrolled for Sezary Syndrome
Steven Horwitz, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
6 Previous Clinical Trials
1,625 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Registry for People With T-cell Lymphoma
2023. "A Registry for People With T-cell Lymphoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05978141.
~667 spots leftby Jul 2030
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top